Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randi Hagerman

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Neurotoxicology|May 15, 2010
Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxinsRipon Paul, Isaac N Pessah, Louise Gane, et al.
Pediatric Neurology|July 15, 2020
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X SyndromeElizabeth Berry-Kravis, Joseph P Horrigan, Nicole Tartaglia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2025
Oligodendrocyte Inclusion Pathology in Fragile X-Associated Tremor/Ataxia SyndromeYingratana McLennan, Hassan Aliashrafzadeh, Faith Zirkelbach-Ngai, et al.
Human Molecular Genetics|May 12, 2011
Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndromeEleonora Napoli, Catherine Ross-Inta, Sarah Wong, et al.
Frontiers in Genetics|October 4, 2018
Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With ParkinsonismXiao-Hong Wang, Jin-Chen Yang, Robert Soohoo, et al.
Journal of Neurodevelopmental Disorders|November 26, 2022
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, et al.
Brain Communications|January 9, 2026
Progression of fragile X-associated tremor/ataxia syndrome revealed by subtype and stage inferenceDouglas Ezra Morrison, Matthew Dominic Ponzini, Ellery R Santos, et al.
Human Molecular Genetics|August 15, 2018
Protein synthesis levels are increased in a subset of individuals with fragile X syndromeSébastien Jacquemont, Laura Pacini, Aia E Jønch, et al.
Human Molecular Genetics|March 29, 2018
Protein synthesis levels are increased in a subset of individuals with fragile X syndromeSébastien Jacquemont, Laura Pacini, Aia E Jønch, et al.
Science Translational Medicine|January 15, 2016
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trialsElizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Neurotoxicology|May 15, 2010
Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxinsRipon Paul, Isaac N Pessah, Louise Gane, et al.
Pediatric Neurology|July 15, 2020
A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Fragile X SyndromeElizabeth Berry-Kravis, Joseph P Horrigan, Nicole Tartaglia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2025
Oligodendrocyte Inclusion Pathology in Fragile X-Associated Tremor/Ataxia SyndromeYingratana McLennan, Hassan Aliashrafzadeh, Faith Zirkelbach-Ngai, et al.
Human Molecular Genetics|May 12, 2011
Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndromeEleonora Napoli, Catherine Ross-Inta, Sarah Wong, et al.
Frontiers in Genetics|October 4, 2018
Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With ParkinsonismXiao-Hong Wang, Jin-Chen Yang, Robert Soohoo, et al.
Journal of Neurodevelopmental Disorders|November 26, 2022
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, et al.
Brain Communications|January 9, 2026
Progression of fragile X-associated tremor/ataxia syndrome revealed by subtype and stage inferenceDouglas Ezra Morrison, Matthew Dominic Ponzini, Ellery R Santos, et al.
Human Molecular Genetics|August 15, 2018
Protein synthesis levels are increased in a subset of individuals with fragile X syndromeSébastien Jacquemont, Laura Pacini, Aia E Jønch, et al.
Human Molecular Genetics|March 29, 2018
Protein synthesis levels are increased in a subset of individuals with fragile X syndromeSébastien Jacquemont, Laura Pacini, Aia E Jønch, et al.
Science Translational Medicine|January 15, 2016
Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trialsElizabeth Berry-Kravis, Vincent Des Portes, Randi Hagerman, et al.
Pageof 16